Drug Type AAV based gene therapy |
Synonyms AAV-emxABE-gOTOF |
Target |
Mechanism OTOF Q829X modulators, OTOF modulators(otoferlin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hearing Disorders | Preclinical | CN | 06 Dec 2023 |